SanUwave sets revenue expectations for the third quarter between $12 million and $12.7 million, with the new applicator production approaching launch.
In a recent statement, Morgan C. Frank, CEO of SANUWAVE Health, Inc. (SNWV), highlighted the company's impressive Q2 2025 financial results. The quarter saw record revenues of $10.2 million, a significant 42% increase compared to Q2 2024.
The strong performance was underpinned by the sale of 116 UltraMist® systems, up from 72 in the previous year's Q2. The revenue from UltraMist® consumables also saw a 37% increase, reaching $6.4 million.
The improved gross margin rose to 78.3%, up from 73.2% in Q2 2024. Operating income stood at $1.9 million, net income was $1.1 million, and adjusted EBITDA more than doubled to $3.4 million, compared to $1.5 million in Q2 2024.
Looking ahead, SANUWAVE Health has provided guidance for Q3 2025, with revenues expected to be between $12 million and $12.7 million. The company also maintained its full-year 2025 revenue guidance of $48-$50 million, representing 47-53% growth over 2024.
While revenue and profitability have improved, the company has identified operating expenses and balance sheet leverage as areas of attention moving forward. However, SANUWAVE Health emphasized its ongoing sales momentum and improving margins. The company also highlighted the upcoming launch of a new UltraMist® applicator design in Q4 2025, which is expected to further boost margins and EBITDA expansion in 2026.
In conclusion, Q2 2025 was another strong performance for SANUWAVE Health, with the quarter contributing significantly to the overall growth of the company for the first 6 months of 2025. The company's focus on improving margins and reducing expenses, coupled with the upcoming launch of the new UltraMist® applicator, positions SANUWAVE Health well for continued growth in the future.
[1] SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Release. (n.d.). Retrieved from https://www.sanuwave.com/investors/financial-reports
[2] SANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call Transcript. (n.d.). Retrieved from https://seekingalpha.com/pr/3793098-sanuwave-health-inc-earnings-call-transcript-q2-2025?page=2
The strong financial results of SANUWAVE Health, Inc. (SNWV) in Q2 2025, with a focus on health solutions like the UltraMist® systems, demonstrate the potential for growth in the financial and business sectors. As the company moves forward, managing operating expenses and balance sheet leverage will be crucial while anticipating the launch of a new UltraMist® applicator design, which could further enhance profits and margins.
